Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Peripheral immune indicators and their predictive value in disease progression or relapse of pediatric Langerhans cell histiocytosis
Hua-Lin Li; Hong-Yun Lian; Wen-Yu Gong; Shuo Tian; Wei-Jing Li; Qing Zhang; Chan-Juan Wang; Hong-Hao Ma; Dong Wang; Yun-Ze Zhao; Zi-Jing Zhao; Jia-Jia Dong; Zhi-Gang Li; Rui Zhang; Lei Cui;
10.1016/j.jped.2025.101466
Efficacy and safety of using Elexacaftor/Tezacaftor/Ivacaftor in the treatment of children with cystic fibrosis: real-world evidence from Brazil
Guilherme da Silva Martins; Carolina Rambo; Gabriela Spessatto; Maitê Milagres Saab; Bruno Hernandes David João; Aline Didoni Fajardo; Juliana Gonçalves Primon; Thalita Gonçalves Picciani; Roberta Corrêa da Cunha; Herberto José Chong-Neto; Carlos Roberto Lebarbenchon Massignan; Luiz Vicente Ribeiro Ferreira da Silva-Filho; Carlos Antônio Riedi; Nelson Augusto Rosário Filho; Débora Carla Chong-Silva;
J Pediatr (Rio J). 2025;101:
Predictive value of clinical indicators in children with community-acquired pneumonia complicated with Kawasaki disease
Yuanhui Duan; Yuexu Ou; Xiaoming Gan; Jieling Li; Jie Cao;
J Pediatr (Rio J). 2025;101: